Novembro Azul Drives Fresh Push on Prostate Cancer Screening in Brazil

Episode 158 of G1’s Eu Te Explico features urologist Lucas Batista Teixeira and a 41-year-old patient discussing awareness, diagnosis and treatment. Health guidance in the coverage stresses that early detection can reach about 90% cure rates and allows less invasive options. The PSA blood test and the digital rectal exam are presented as the main tools for prostate cancer screening. The Ministry of Health highlights higher risk with advancing age, family history of early-onset cases and overweight or obesity. Laboratório Sancet promotes November check-up packages that include total and free PSA and broader hormonal and metabolic panels to facilitate screening.